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Background: Children with autism spectrum disorder (ASD) often have co-occurring symptoms of attention-deficit/
hyperactivity disorder (ADHD) and/or anxiety. It is unclear whether these disorders arise from shared or distinct
developmental pathways. We explored this question by testing the specificity of early-life (infant and toddler)
predictors of mid-childhood ADHD and anxiety symptoms compared to ASD symptoms. Methods: Infants (n = 104)
at high and low familial risk for ASD took part in research assessments at 7, 14, 24 and 38 months, and 7 years of
age. Symptoms of ASD, ADHD and anxiety were measured by parent report at age 7. Activity levels and inhibitory
control, also measured by parent report, in infancy and toddlerhood were used as early-life predictors of ADHD
symptoms. Fearfulness and shyness measured in infancy and toddlerhood were used as early-life predictors of
anxiety symptoms. Correlations and path analysis models tested associations between early-life predictors and mid-
childhood ADHD and anxiety symptoms compared to mid-childhood ASD symptoms, and the influence of controlling
for ASD symptoms on those associations. Results: Increased activity levels and poor inhibitory control were
correlated with ADHD symptoms and not ASD or anxiety; these associations were unchanged in path models
controlling for risk-group and ASD symptoms. Increased fearfulness and shyness were correlated with anxiety
symptoms, but also ASD symptoms. When controlling for risk-group in path analysis, the association between
shyness and anxiety became nonsignificant, and when further controlling for ASD symptoms the association between
fearfulness and anxiety became marginal. Conclusions: The specificity of early-life predictors to ADHD symptoms
suggests early developmental pathways to ADHD might be distinct from ASD. The overlap in early-life predictors of
anxiety and ASD suggests that these disorders are difficult to differentiate early in life, which could reflect the
presence of common developmental pathways or convergence in early behavioural manifestations of these disorders.
Keywords: Autism spectrum disorder; attention-deficit/hyperactivity disorder; anxiety; comorbidity; early
developmental pathways.
Introduction
Autism spectrum disorder (ASD) is a neurodevelop-
mental condition characterised by social communi-
cation deficits, restricted and repetitive behaviours
and sensory atypicalities (DSM-5; American Psychi-
atric Association, 2013). Many children with ASD
also have symptoms of other neurodevelopmental
disorders; two of the most frequently co-occurring
conditions in ASD are attention-deficit/hyperactivity
disorder (ADHD), characterised by developmentally
inappropriate inattention, hyperactivity and impul-
sivity, and anxiety (Simonoff et al., 2008; Tick et al.,
2016). Twin studies indicate shared genetic factors
contribute to the frequent co-occurrence of ADHD
and anxiety in ASD (Hallett, Ronald, Rijsdijk, &
Happe, 2010; Taylor et al., 2013; Tick et al., 2016),
but beyond this, the reasons for the overlap between
these disorders are not fully understood. In partic-
ular, it is unclear if ADHD and anxiety in ASD reflect
the coexistence of distinct disorders with indepen-
dent causal pathways. Alternatively, these disorders
might arise from common causal pathways. For
example, co-occurring ADHD and anxiety symptoms
could be a secondary consequence of ASD symp-
tomatology, or ASD, ADHD, and anxiety could reflect
different manifestations of the same underlying
pathophysiological condition (Rommelse, Geurts,
Franke, Buitelaar, & Hartman, 2011; Wood &
Gadow, 2010). Distinguishing whether causal path-
ways are shared or distinct is important for under-
standing the nature of the co-occurrence and
aetiology of these three disorders.
Longitudinal analyses of causal associations
between ASD and ADHD/anxiety traits across mid-
to-late childhood have shown that ADHD traits more
strongly predict later ASD traits than vice versa
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(Taylor et al., 2013; Tick et al., 2016), while ASD
traits more strongly predict later anxiety traits than
vice versa (Hallett et al., 2010; Tick et al., 2016).
These findings suggest that ADHD symptoms are
not simply a secondary consequence of ASD traits,
while this may be the case for anxiety. Experimental
studies in children have revealed separable neu-
rocognitive abnormalities that are specifically asso-
ciated with ASD and ADHD, and these ASD- and
ADHD-related abnormalities manifest in children
with both disorders (Groom et al., 2017; Tye et al.,
2014). These findings suggest that ASD and ADHD
are dissociable in terms of brain function and that
co-occurring ASD and ADHD reflects the coexistence
of two distinct disorders. In contrast, neurocognitive
abnormalities associated with anxiety (without ASD)
have been reported to be absent in children with
ASD and co-occurring anxiety (Hollocks, Ozsivad-
jian, Matthews, Howlin, & Simonoff, 2013; May,
Cornish, & Rinehart, 2015), suggesting the neu-
rocognitive basis of anxiety within ASD differs from
anxiety outside of ASD, perhaps because anxiety is,
in these cases, a secondary consequence of ASD
symptoms.
One limitation of investigating the co-occurrence
of these disorders in childhood is that once symp-
toms are established it is difficult to disentangle
whether they are caused by each other, independent
pathophysiological mechanisms, compensatory pro-
cesses, or the results of atypical developmental
experiences (Johnson, Gliga, Jones, & Charman,
2015). An ideal method of investigating causal
pathways leading to co-occurring ADHD and anxiety
symptoms in ASD is therefore to study their origins
in infancy and track their development into child-
hood (Johnson et al., 2015). Prospective longitudi-
nal studies have investigated the early (infancy to
childhood) developmental pathways that lead to
ASD, ADHD, and anxiety independently and have
identified early-life atypicalities that precede the
onset of symptoms. For instance, difficulties disen-
gaging visual attention, altered neurocognitive pro-
cessing of social stimuli, and poor self-regulation in
infancy and toddlerhood predict later ASD symp-
toms (Jones, Gliga, Bedford, Charman, & Johnson,
2014; Szatmari et al., 2016). Increased locomotor
activity and poor inhibitory control in infancy and
toddlerhood and abnormal development of sus-
tained visual attention (lack of improvement over
time) predict higher childhood ADHD symptoms
(Einziger et al., 2017; Miller, Iosif, Young, Hill, &
Ozonoff, 2016; Willoughby, Gottfredson, & Stifter,
2017). High levels of infant and toddler fearfulness
and shyness predict later anxiety symptoms (Gart-
stein et al., 2010; Prior, Smart, Sanson, & Oberk-
laid, 2000).
Few prospective longitudinal studies have
explored early developmental pathways to these
disorders simultaneously. In a population sample,
Elberling et al. (2014) reported that abnormal
activity (e.g. hyperactivity) and interests (e.g. lack
of interest in play) in infancy predicted symptoms of
both ASD and ADHD in early-to-mid childhood,
suggesting these disorders might have similar ori-
gins in infancy and overlapping developmental path-
ways. However, activity and interests were combined
in one variable, and it is possible that activity
predicted ADHD while interests predicted ASD.
Tonnsen, Malone, Hatton, and Roberts (2013)
reported that increased infant and toddler fearful-
ness and reduced soothability were associated with
early-childhood anxiety symptoms but not ASD
symptoms in children with Fragile X syndrome,
suggesting early developmental pathways to anxiety
might be separable from ASD. Drawing conclusions
from these studies is complicated, however, as the
analyses tested whether early-life variables predicted
each childhood disorder in separate models without
controlling for symptoms of the other disorder/s.
In this study, we used longitudinal statistical
modelling to test whether pathways to ADHD and
anxiety were shared with or distinct from ASD. We
tested, first, whether behavioural atypicalities in
infancy and toddlerhood that have previously been
associated with ADHD (increased locomotor activity,
poor inhibitory control and sustained attention) were
associated with mid-childhood symptoms of ADHD
but not ASD or anxiety, and whether atypicalities in
infancy and toddlerhood that have previously been
associated with anxiety (high fearfulness and shy-
ness) were associated with mid-childhood symptoms
of anxiety but not ASD or ADHD. Second, we tested
the specificity of those associations to ADHD and
anxiety while controlling for the influence of ASD
symptoms. We investigated this in a sample of
infants at familial high-risk for ASD (due to having
an older sibling with ASD) studied prospectively into
mid-childhood. Around 20% of high-risk infants
develop ASD (Ozonoff et al., 2011) and another
~20% show other atypical developmental outcomes,
including subclinical ASD traits, developmental
delay, and symptoms of ADHD and anxiety (Miller,
Iosif, Young, Hill, Phelps Hanzel et al., 2016; Ozonoff
et al., 2014). Thus, our sample was defined based on
risk for ASD but was also enriched for symptoms of
ADHD and anxiety. We also included a sample of
children at low-risk for ASD studied prospectively
alongside the high-risk group and controlled for
effects of risk-group in analyses.
Methods
Participants
As part of the British Autism Study of Infant Siblings (BASIS;
www.basisnetwork.org), 104 infants took part in research
assessments at 7, 14, 24 and 38 months and were invited to
return for a follow-up study at age 7 years. At enrolment, each
high-risk (HR) infant (n = 54) had an older sibling (in four
cases, a half-sibling) with a community clinical ASD diagnosis,
confirmed using the Development and Well-Being Assessment
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(DAWBA; Goodman, Ford, Richards, Gatward, & Meltzer,
2000) and the Social Communication Questionnaire (SCQ;
Rutter, Bailey, & Lord, 2003) by expert clinicians on our team
(TC, PB).1 Low-risk (LR) controls (n = 50) were full-term infants
(one exception) recruited from a volunteer database at the
Birkbeck Centre for Brain and Cognitive Development. At
enrolment, all LR infants had at least one older sibling; the
SCQ was used to confirm absence of ASD in older siblings, with
no child scoring above instrument cutoff (≥15, n = 1 missing
data). Not all children were retained at the 7-year assessment
(44 HR and 37 LR participated; see online Supporting Infor-
mation for retention analysis). However, all 104 children were
included in analyses and missing data were handled in
statistical modelling using full information maximum likeli-
hood (FIML; see Statistical Analysis below). Ethics approval
was obtained from the NHS National Research Ethics Service
(NHS RES London REC 08/H0718/76; 14/LO/0170). Parental
written informed consent was obtained at all visits; child’s
written assent was obtained at the mid-childhood visit.
Measures
Mid-childhood assessments.
ADHD and anxiety: The parent-rated Conners 3 (Con-
ners, 2008) was used to measure symptoms of ADHD (rated
over the 6 months before testing). T-scores (mean 50; SD 10;
minimum-maximum score ≤30 to ≥90) for the DSM-IV-TR
(American Psychiatric Association, 2000) Inattention and
Hyperactivity/Impulsivity domains were used in analyses.
The parent-report Spence Children’s Anxiety Scale (SCAS;
Spence, 1998) was used to assess current symptoms of
anxiety. The SCAS is based on DSM-IV-TR (American Psychi-
atric Association, 2000) criteria for anxiety disorders. The Total
Anxiety score (minimum-maximum score 0–144) was used in
analyses. None of the children had a clinical diagnosis of
ADHD or anxiety according to parent report.
ASD: A battery of assessments was used to measure ASD
symptoms and assign research diagnoses of ASD (see online
Supporting Information for full details). Forty-two of 44 HR and
all 37 LR children completed the ASD assessments required for
diagnostic evaluation in mid-childhood. Of these, 15 HR
children met DSM-5 criteria for ASD and the remaining 27
HR and 37 LR children did not. A parent-report measure of
ASD symptoms (rated over the 6 months prior to testing), the
Social Responsiveness Scale – 2 (SRS-2; Constantino, 2012),
was used in the current analysis to be compatible with the
parent-report ADHD and anxiety measures. Age-normed SRS-
2 T-scores (mean 50; SD 10; minimum-maximum ≤30 to ≥90)
were used in analysis.
IQ: The Wechsler Abbreviated Scale of Intelligence – Second
Edition (WASI-II; Wechsler, 2011) was used to measure IQ. The
age-normed full-scale intelligence quotient (FSIQ; mean 100,
SD 15) was computed for each child.
Early-life predictors of ADHD and anxiety. Early-
life behaviours predicted to be associated with later ADHD
(locomotor activity, inhibitory control, sustained attention) and
anxiety (fearfulness and shyness) were measured at the 7- and
14-month visits using the Infant Behavior Questionnaire-
Revised (IBQ-R, Gartstein & Rothbart, 2003) and at the 24-
month visit with the Early Child Behavior Questionnaire
(ECBQ, Putnam, Gartstein, & Rothbart, 2006). The IBQ-R
(191 items) and ECBQ (201 items) are measures of tempera-
ment in which parents rate the frequency with which their
infant/toddler exhibits particular behaviours in everyday
contexts on a 7-point scale (never to always). Parents rate
their child’s behaviour over the past week (IBQ-R) or past
2 weeks (ECBQ). IBQ-R/ECBQ items are averaged to yield
subscales indexing different temperament dimensions, which
show high continuity across instruments (Putnam, Rothbart,
& Gartstein, 2008) and are therefore ideal for examining
developmental pathways.
ADHD predictors: Locomotor activity was indexed by the
IBQ-R and ECBQ Activity level subscale at 7, 14 and
24 months. This subscale assesses the amount of limb move-
ment, squirming and locomotor activity (IBQ-R) and the rate
and intensity of gross motor activity (ECBQ). Inhibitory control
was indexed by the ECBQ Inhibitory Control subscale at
24 months (no IBQ-R scale measures inhibitory control),
which assesses the capacity to stop, moderate or refrain from
behaviours under instruction. Sustained attention was
indexed by the Duration of Orienting IBQ-R subscale at 7 and
14 months, which measures attention to/interaction with an
object for extended time periods, and the Attentional Focusing
ECBQ subscale at 24 months, which measures sustained
orienting to an object and resisting distraction. Example items
for these scales are provided in the online Supporting Infor-
mation. Higher scores reflect higher activity levels and better
inhibitory control and attention.
Anxiety predictors: Fearfulness was indexed by the IBQ-
R and ECBQ Fear subscale at 7, 14 and 24 months. This
subscale measures distress/startle to sudden environmental
changes and inhibited approach to novelty (IBQ-R), and startle
to sudden events and negative affect related to anticipated
pain, distress, and potentially threatening situations (ECBQ).
Shyness was indexed by the ECBQ Shyness subscale at
24 months (no IBQ-R subscale indexes shyness), which mea-
sures slow/inhibited approach or discomfort in novel/uncer-
tain social situations. Example items are provided in the online
Supporting Information. Higher scores reflect higher fearful-
ness and shyness.
Statistical analysis
As a first step, we computed Pearson correlation coefficients
between early-life predictors and mid-childhood symptoms of
ADHD, anxiety, and ASD to examine how our hypothesised
individual predictors and symptom domains were related to
one another, before controlling for the influence of other
variables and assessing the specificity of associations with
ADHD and anxiety compared to ASD. ADHD, anxiety and ASD
symptom scores were skewed and so an lnskew0 transforma-
tion was applied using Stata (StataCorp, 2013) prior to
analysis, which normalised all scores (Shapiro–Wilk p-values
>.11). The a level was set to .05, with correlations considered
statistically significant from zero if the p obtained was <.05. In
addition, we highlight associations that remained significant
with a Bonferroni-corrected alpha level of .001 (a = .05/
50 = .001), with correlations considered statistically signifi-
cant if the obtained p was <.001. Early-life variables that were
not significantly associated with mid-childhood symptoms in
the Pearson correlations were not included in the next stage of
analysis (longitudinal path analysis) to limit the number of
variables entered into longitudinal models given our modest
sample size.
In the next stage of analysis, we used path analysis run
using Mplus (Muthen & Muthen, 1998–2012) to test whether
associations between early-life predictors and mid-childhood
ADHD and anxiety symptoms were specific to those disorder
symptoms (compared to ASD symptoms) and would hold while
controlling for ASD symptoms. Missing data were considered
missing at random and were analysed using full information
maximum likelihood (FIML) methods (Enders & Bandalos,
2001). FIML is an effective method for analysing longitudinal
data with missing data and has been demonstrated to provide
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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less biased parameter estimates then listwise deletion (Enders,
2013; Widaman, 2006). Standardised model estimates
(STDYX) are reported throughout. For predictors measured
over multiple time-points (activity level and fear), ‘Activity’ and
‘Fear’ factors were created by fixing the first factor loading with
7-month activity level (or fear) at 1. This confirmatory factor
analytic approach involves loading the measures, or indicator
variables, from each of the three measurement occasions onto
a single factor, essentially collapsing across time to give a
weighted average, which accounts for measurement error. In
Model 1a, these factors, together with risk-group (high-risk
coded ‘1’ vs. low-risk coded ‘0’), were used as predictors of mid-
childhood ADHD, anxiety and ASD symptoms to test whether
Activity would be associated with later ADHD symptoms (and
not ASD or anxiety) and Fear would be associated with later
anxiety symptoms (and not ASD or ADHD). In Model 1b,
mid-childhood ASD symptoms were included as a predictor
of ADHD and anxiety symptoms, rather than a correlated
outcome, to assess whether controlling for ASD would affect
associations between Activity and ADHD and Fear and
anxiety.
Models 2a&b were saturated path analysis models assessing
the association between inhibitory control and shyness (mea-
sured only at 24 months) and mid-childhood ADHD, anxiety
and ASD symptoms. Model 2a included inhibitory control,
shyness and risk-group as predictors of ADHD, anxiety and
ASD symptoms to test whether inhibitory control would be
associated with mid-childhood ADHD symptoms (not ASD or
anxiety) and shyness would be associated with mid-childhood
anxiety symptoms (and not ASD or ADHD). Model 2b included
mid-childhood ASD symptoms as a predictor rather than an
outcome to assess whether controlling for ASD symptoms
affected associations between inhibitory control and ADHD
and shyness and anxiety.
We repeated these models including 1) ASD outcome rather
than dimensional ASD symptoms as a covariate to assess
whether the 15 HR children with ASD in mid-childhood were
driving effects; 2) sex and IQ as covariates to test whether these
variables influenced associations; and 3) an interaction term
between risk-group and each early-life predictor to check our
assumption that associations between predictors and mid-
childhood symptoms would be similar in HR and LR groups.
Due to space limitations, these additional models are reported
and discussed in the online Supporting Information.
Results
Sample characteristics
Sample characteristics are presented in Table 1. The
HR and LR groups did not differ in age or sex at any
time-point. The HR group had higher mid-childhood
hyperactivity/impulsivity, inattention, anxiety, and
ASD scores, lower mid-childhood IQ scores, and
lower inhibitory control and higher shyness scores at
24 months than the LR group.
Correlations between early-life predictors and mid-
childhood ADHD, anxiety and ASD symptoms
Correlations between early-life predictors and mid-
childhood ADHD, anxiety, and ASD symptoms are
summarised in Table 2 and reported in the online
Supporting Information. Inattentive symptoms were
associated with higher activity levels and fear and
lower inhibitory control at 24 months. Hyperactive/
impulsive symptoms were associated with higher
activity levels at all time-points, higher fear at
24 months, and lower inhibitory control at
24 months. Anxiety symptoms were associated with
higher fear at 14 and 24 months, higher activity
levels at 14 months, and higher shyness at
24 months. ASD symptoms were associated with
higher fear at 14 and 24 months, higher activity
levels at 14 months, and higher 24 months shyness.
ADHD, anxiety and ASD symptoms were signifi-
cantly positively associated with one another.
Model 1a: Specificity of associations between early-
life activity level and fear and mid-childhood ADHD
and anxiety symptoms, respectively, compared to
mid-childhood ASD symptoms
A path analysis model (Figure 1) using a maximum
likelihood estimator provided a good fit to the data
(v2(28) = 32.41, p = .26; comparative fit index, CFI =
0.99; root-mean-square error adjusted, RMSEA =
0.039). For the ‘Fear’ factor, all standardised factor
loadings (SFL) were significant (7-month SFL = 0.67,
p < .001; 14 month SFL = 0.79, p < .001; 24 month
SFL = 0.64, p < .001). Similarly, for the ‘Activity’
factor, factor loadings for all time-points were signif-
icant (7-month SFL = 0.69, p < .001; 14 month
SFL = 0.81, p < .001; 24 month SFL = 0.61, p <
.001). Fear and Activity were significantly positively
correlated (r = .54, p < .001). Table 3 shows the stan-
dardisedbetacoefficients andcorrespondingp-values
for each path in the model. Activity was significantly
associated with mid-childhood hyperactivity/impul-
sivity and inattention, with higher activity levels
across infancy and toddlerhood associated with
higherADHDsymptoms.Activitywasnot significantly
associatedwithASDor anxiety. Fearwas significantly
associated with later anxiety, with higher infant and
toddler fearassociatedwithhigheranxiety symptoms,
but was not significantly associated with ASD or
ADHD. Risk-group was marginally associated with
hyperactivity/impulsivity and significantly with inat-
tention, anxiety and ASD, with higher symptoms in
the high-risk siblings.
Model 1b: Associations between early-life activity
and fear and mid-childhood ADHD and anxiety,
respectively, controlling for ASD symptoms
In Model 1b, Model 1a was rerun controlling for ASD
symptoms, rather than treating them as a correlated
outcome. Model fit was good: v2(28) = 32.53, p = .25,
CFI = 0.98, RMSEA = 0.039. Factor loadings and the
correlation between factors were unchanged from
Model 1a. Activity remained a significant predictor of
ADHD symptoms and not anxiety while controlling
for ASD symptoms (Table 3). For Fear, the significant
association with anxiety in Model 1a became mar-
ginal, with higher Fear marginally associated with
higher anxiety. The nonsignificant association
between Fear and ADHD in Model 1a also became
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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marginally significant, with higher Fear associated
with lower ADHD symptoms. ASD symptoms were
significantly associated with higher hyperactive/
impulsive and inattentive symptoms, but not with
anxiety. The effect of risk-group on hyperactivity/
impulsivity and inattention became nonsignificant
Table 1 Group characteristics and group means for symptoms in mid-childhood (age 7 years) and early-life predictor measures (age
7, 14, 24 months). Means (SD) by HR and LR group
HR group LR group Group differences
7-year measures
Sex (N girls: N boys) 28:16 22:15 n/s
Age (months) 90.81 (6.33) 89.34 (4.81) n/s
N (girls) 43 (27) 35 (21)
Conners Inattention 57.07 (13.95) 51.22 (9.40) t (72.30) = 2.21, p = .03, d = .49
N (girls) 42 (26) 37 (22)
Conners Hyp/Imp 59.26 (16.59) 52.16 (11.58) t (73.35) = 2.23, p = .03, d = .50
N (girls) 42 (26) 37 (22)
SCAS Total Anxiety 21.16 (14.25) 12.22 (7.27) t (77) = 3.41, p = .001a, d = .79
N (girls) 43 (27) 36 (22)
SRS-2 T-score 59.27 (19.63) 45.49 (5.82) t (42.62) = 4.07, p < .001a, d = .95
N (girls) 37 (23) 35 (21)
WASI-II FSIQ 109.34 (16.29) 117.06 (11.61) t (74) = 2.34, p = .02, d = .55
N (girls) 41 (27) 35 (21)
Transf. Inattention 3.02 (0.58) 2.77 (0.54)
Transf. Hyp/Imp 2.87 (0.78) 2.55 (0.69)
Transf. SCAS 2.87 (0.57) 2.31 (0.60)
Transf. SRS-2 2.66 (0.99) 1.81 (0.78)
7-month measures
Sex (N girls: N boys) 33:21 29:21 n/s
Age (months) 7.31 (1.19) 7.38 (1.24) n/s
N (girls) 54 (33) 50 (29)
Activity level 4.19 (0.97) 4.28 (0.84) n/s
N (girls) 52 (31) 49 (28)
Orienting 3.41 (1.26) 3.63 (0.84) n/s
N (girls) 52 (31) 49 (28)
Fear 2.74 (1.16) 2.50 (0.94) n/s
N (girls) 52 (31) 49 (28)
14-month measures
Sex (N girls: N boys) 32:21 28:20 n/s
Age (months) 13.68 (1.57) 13.92 (1.33) n/s
N (girls) 53 (32) 48 (28)
Activity level 4.32 (0.92) 4.08 (0.71) n/s
N (girls) 51 (30) 47 (27)
Orienting 3.28 (1.03) 3.64 (0.92) n/s
N (girls) 51 (30) 47 (27)
Fear 3.33 (1.20) 2.95 (0.93) n/s
N (girls) 51 (30) 47 (27)
24-month measures
Sex (N girls: N boys) 32:20 27:20 n/s
Age (months) 23.92 (1.15) 23.87 (0.68) n/s
N (girls) 53 (32) 47 (27)
Activity level 4.86 (0.93) 4.72 (0.79) n/s
N (girls) 46 (28) 47 (27)
Attentional focus 4.12 (0.88) 4.28 (0.76) n/s
N (girls) 46 (28) 47 (27)
Fear 2.44 (1.01) 2.21 (0.53) n/s
N (girls) 46 (28) 47 (27)
Inhibitory control 3.53 (0.97) 4.03 (1.02) t (91) = 2.40, p = .02, d = .50
N (girls) 46 (28) 47 (27)
Shyness 3.41 (1.06) 2.82 (0.79) t (91) = 3.07, p = .003, d = .63
N (girls) 46 (28) 47 (27)
N (girls) = the number of participants in each group that completed each measure and the number of children completing the
measure that were girls. Conners Inattention and Hyp/Imp = Conners 3 T-scores for DSM-IV Inattentive and Hyperactive/Impulsive
domains. SCAS Total Anxiety = Spence Children’s Anxiety Scale Total Anxiety score. SRS-2 = Social Responsiveness Scale – 2.
Transf. Inattention, Hyp/Imp, SCAS, SRS-2 = Conners Inattention and Hyperactive/Impulsive T-scores, SCAS Total Anxiety scores,
and SRS-2 T-scores following lnkskew0 transformation. WASI-II FSIQ = Wechsler Abbreviated Scale of Intelligence – 2nd Edition
full-scale IQ. Superscript ‘a’ indicates comparisons that remained significant after applying Bonferroni correction for multiple
testing (a = .05/24 = .002). Note that corrected df and p-values are reported wherever the assumption of equal variances was
violated in t-tests.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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after accounting for ASD symptoms, but risk-group
remained a significant predictor of anxiety.
Model 2a: Specificity of associations between early-
life inhibitory control and shyness and mid-
childhood ADHD and anxiety, respectively,
compared to mid-childhood ASD symptoms
A saturated path analysis model was run using
maximum likelihood estimation to assess the asso-
ciation between 24-month inhibitory control and
shyness with mid-childhood ADHD, anxiety and
ASD symptoms, controlling for risk-group (Figure 2).
Inhibitory control and shyness were not significantly
associated with each other (r = .14, p = .162).
Inhibitory control was significantly associated with
inattentive and hyperactive/impulsive symptoms,
with lower inhibitory control in toddlerhood associ-
ated with greater mid-childhood ADHD symptoms,
but was not significantly associated with ASD or
anxiety (Table 3). Shyness was not significantly
associated with mid-childhood anxiety or ADHD
symptoms, but higher shyness was associated with
increased mid-childhood ASD symptoms. Risk-
group was not significantly related to ADHD symp-
toms over and above shyness and inhibitory control,
but was significantly related to anxiety and ASD,
with higher symptoms in the high-risk siblings.
Model 2b: Associations between early-life inhibitory
control and shyness and mid-childhood ADHD and
anxiety, respectively, controlling for ASD symptoms
In Model 2b, we added ASD symptoms as a covariate,
rather than a correlated outcome. Inhibitory control
remained a significant predictor of ADHD symptoms
and not anxiety while controlling for ASD symptoms
(Table 3). Shyness did not significantly predict anx-
iety or ADHD. Risk-group remained a significant
predictor of anxiety, and not ADHD. ASD symptoms
were significantly associated with higher levels of
inattention, hyperactivity/impulsivity and anxiety.
Interactions with risk-group and effects of
controlling for IQ, sex and ASD outcome
Results of additional models controlling for potential
confounding variables are reported and discussed in
full in the online Supporting Information. Risk-group
did not interact with early-life predictor variables for
our hypothesised pathways to ADHD or anxiety,
though risk-group did interact with shyness in
predicting ADHD. Model results were not affected
by covarying IQ. Controlling for ASD outcome
produced similar findings to those reported in
Models 1b&2b. Covarying for sex revealed a signif-
icant negative association between fearfulness and
ADHD symptoms but did not affect our pathways of
interest.
Discussion
Early developmental pathways to symptoms of
ADHD compared to ASD symptoms
Increased early-life locomotor activity and poor
inhibitory control were correlated with mid-child-
hood ADHD symptoms but (except 14-month activ-
ity) not with ASD or anxiety. In path analysis, activity
levels and inhibitory control were specifically
Figure 1 Model 1a: Path analysis model showing associations between infant Fear and Activity factors and later symptoms of ADHD, ASD
and anxiety. Black arrows indicate significant effects at p < .05. Grey arrows are nonsignificant effects. Key pathways of interest are in
bold with standardised beta values attached. Correlations between symptoms of ADHD, anxiety and ASD were included in the model but
are not shown in the diagram for simplicity
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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associated with ADHD and not ASD or anxiety, and
these associations remained when controlling for
ASD symptoms and risk-group. It has been argued
that no neurocognitive or behavioural domain is
impaired in ADHD and not in ASD and vice versa;
consequently, these disorders must share patho-
physiological mechanisms and represent different
manifestations of the same underlying condition
(Rommelse et al., 2011). Contrary to this view, our
findings revealed early-life atypicalities that were
unique to ADHD symptoms and not shared by ASD,
indicating these disorders may have distinct devel-
opmental origins and are therefore unlikely to reflect
a common condition. Our findings are consistent
with work in older children reporting dissociable
neurocognitive abnormalities in ADHD and ASD
(Groom et al., 2017; Tye et al., 2014) and longitudi-
nal analyses suggesting that ADHD traits are not
simply a consequence of ASD traits (Taylor et al.,
2013; Tick et al., 2016). Our findings also replicate
previously reported associations between increased
activity levels and poor inhibitory control in infancy
and toddlerhood and later ADHD symptoms (Einzi-
ger et al., 2017; Willoughby et al., 2017). We extend
this work by showing these early-life atypicalities
specifically predict later ADHD and not ASD or
anxiety within our sample.
In contrast to previous work (Miller, Iosif, Young,
Hill, & Ozonoff, 2016), early-life sustained attention
was not associated with mid-childhood ADHD symp-
toms. However, Miller, Iosif, Young, Hill, and Ozonoff
(2016) used eye-tracking to measure infants’
sustained attention to on-screen stimuli while we
used parent-report ratings of infants’ ability to
maintain attention during everyday activities. These
methods provide complementary information about
developing attentional abilities, and it is possible
that eye-tracking methods are more sensitive to
early-life atypicalities in sustained attention associ-
ated with later ADHD, while behaviourally observed
difficulties with sustained attention emerge later in
development.
Early developmental pathways to symptoms of
anxiety compared to ASD
Higher early-life fearfulness and shyness were cor-
related with mid-childhood anxiety symptoms,
before controlling for ASD and risk-group. However,
fearfulness and shyness were also correlated with
mid-childhood ASD symptoms. Thus, early-life atyp-
icalities previously associated with anxiety (Gart-
stein et al., 2010; Prior et al., 2000) appeared not to
be specific to anxiety, but rather were shared with
ASD symptoms. In path analysis, fearfulness
remained significantly predictive of anxiety when
controlling for risk-group but became marginal when
controlling for ASD symptoms. Shyness did not
predict anxiety when controlling for risk-group or
ASD, but did predict ASD when controlling for risk-
group. These findings indicate that at least part of
the association between fear/shyness and anxiety
detected in correlations was driven by ASD
Table 3 Summary of path analysis results. Standardised beta
coefficients with their p-values and 95% confidence intervals
are shown for each path in Models 1a&b and 2a&b
Standardised Beta
(95% CI), p value
Model 1a
Activity – Inattention .44, (.12, .75), p = .006*
Activity – Hyp/Imp .72, (.45, .99), p < .001*
Activity – Anxiety .05, (.24, .35), p = .72
Activity – ASD .15, (.17, .46), p = .37
Fear – Inattention .21, (.54, .13), p = .22
Fear – Hyp/Imp .21, (.52, .10), p = .19
Fear – Anxiety .32, (.03, .62), p = .03*
Fear – ASD .22, (.09, .53), p = .16
Risk-group – Inattention .22, (.01, .44), p = .04*
Risk-group – Hyp/Imp .19, (.004, .38), p = .06
Risk-group – Anxiety .36, (.17, .54), p < .001*
Risk-group – ASD .37, (.18, .56), p < .001*
Model 1b
Activity – Inattention .38, (.07, .68), p = .02*
Activity – Hyp/Imp .66, (.39, .93), p < .001*
Activity – Anxiety .03, (.26, .32), p = .85
Fear – Inattention .30, (.61, .02), p = .07
Fear – Hyp/Imp .29, (.59, .00), p = .05
Fear – Anxiety .28, (.01, .58), p = .06
Risk-group – Inattention .08, (.14, .29), p = .50
Risk-group – Hyp/Imp .04, (.15, .23), p = .68
Risk-group – Anxiety .29, (.09, .49), p = .005*
ASD – Inattention .41, (.18, .64), p = .001*
ASD – Hyp/Imp .41, (.20, .62), p < .001*
ASD – Anxiety .18, (.05, .41), p = .12
Model 2a
Inhibition – Inattention .33, (.55, .12), p = .002*
Inhibition – Hyp/Imp .35, (.56, .14), p = .001*
Inhibition – Anxiety .06, (.15, .28), p = .56
Inhibition – ASD .10, (.33, .13), p = .41
Shyness – Inattention .05, (.17, .27), p = .65
Shyness – Hyp/Imp .05, (.16, .27), p = .62
Shyness – Anxiety .16, (.04, .37), p = .12
Shyness – ASD .29, (.08, .50), p = .007*
Risk-group – Inattention .12, (.10, .34), p = .29
Risk-group – Hyp/Imp .11, (.12, .33), p = .35
Risk-group – Anxiety .40, (.20, .60), p < .001*
Risk-group – ASD .31, (.10, .52), p = .004*
Model 2b
Inhibition – Inattention .29, (.49, .09), p = .005*
Inhibition – Hyp/Imp .30, (.49, .10), p = .003*
Inhibition – Anxiety .09, (.12, .30), p = .39
Shyness – Inattention .08, (.29, .14), p = .49
Shyness – Hyp/Imp .10, (.31, .11), p = .34
Shyness – Anxiety .08, (.13, .29), p = .47
Risk-group – Inattention .01, (.23, .21) p = .91
Risk-group – Hyp/Imp .06, (.26, .15), p = .57
Risk-group – Anxiety .31, (.10, .52), p = .004*
ASD – Inattention .43, (.22, .64), p < .001*
ASD – Hyp/Imp .53, (.34, .73), p < .001*
ASD – Anxiety .29, (.07, .51), p = .01*
Significant paths in the models are indicated by asterisks.
Activity = Activity factor reflecting IBQ-R/ECBQ activity level
scores across 7, 14, 24 months. Fear = Fear factor reflecting
IBQ-R/ECBQ fear scores across 7, 14, 24 months. Inattention
= Conners 3 Inattention symptoms. Hyp/Imp = Conners 3
Hyperactive/Impulsive symptoms. ASD = SRS-2 ASD symp-
toms. Anxiety = SCAS Total Anxiety symptoms. Risk-group =
high-risk or low-risk group. Inhibition = 24-month inhibitory
control scores on the ECBQ. Shyness = 24-month shyness
scores on the ECBQ.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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symptomatology. Our pattern of findings suggests
that developmental pathways to anxiety can be
difficult to differentiate from those leading to ASD,
at least in our cohort.
Several possible reasons for the frequent co-
occurrence of anxiety in ASD have been proposed,
including the coexistence of distinct disorders with
independent causal pathways, an ASD-specific vari-
ant of anxiety, and anxiety occurring as a conse-
quence of ASD symptoms (e.g. social interaction
difficulties leading to stress and anxiety) (Wood &
Gadow, 2010). Our findings may be most in line with
the last possibility: early-life markers of anxiety
(without ASD) were associated with later anxiety
here, but were also associated with later ASD symp-
toms. However, it is also possible that our measures
of fearfulness and shyness were not sufficiently
sensitive to differentiate between early behavioural
manifestations of anxiety and ASD. The IBQ-R and
ECBQ items assessing these constructs (see online
Supporting Information for examples) could be
endorsed for several reasons. High scores on Fear
items may have indexed a generally fearful temper-
ament associated with anxiety or early manifesta-
tions of ASD symptoms, such as aversions to
changes in body placement and environment due to
sensory issues or insistence on sameness. Items on
the shyness scale may have detected early-appearing
social atypicalities associated with ASD, such as
lack of interest in social interaction, rather than the
socially inhibited temperament associated with anx-
iety. Future work should investigate other markers
of anxiety in early life that are more clearly disso-
ciable from ASD, such as physiological arousal
measures which have been shown to differentiate
between anxiety and ASD symptoms in older chil-
dren (Chiu, Anagnostou, Brian, Chau, & Kushki,
2016).
Clinical implications
High activity levels and poor inhibitory control in
infancy and toddlerhood may be useful in the early
detection and monitoring of developing ADHD symp-
toms. Early interventions designed to limit the
development of ADHD symptoms may benefit from
targeting the neurocognitive mechanisms that
underlie inhibitory control and increased activity
(Sonuga-Barke & Halperin, 2010). Early-life fearful-
ness and shyness have been proposed as risk-
markers for later-emerging anxiety and have been
targeted in early interventions (Kennedy, Rapee, &
Edwards, 2009). Our findings indicate that these
early-life atypicalities may also detect ASD traits;
consequently, interventions designed to improve
early fearfulness and shyness in the development of
anxiety may also affect early ASD traits.
Our findings also have implications for under-
standing the development of infants at familial high-
risk for ASD. It is known that these infants are
vulnerable to anxiety, ADHD and other atypical
developmental outcomes as well as ASD (Miller,
Iosif, Young, Hill, Phelps Hanzel et al., 2016; Ozonoff
et al., 2014), but few studies (Miller, Iosif, Young,
Hill, & Ozonoff, 2016) have investigated early pre-
dictors of those outcomes. Our findings indicate that
predictors of ADHD symptoms in these children can
be detected in the first year of life. These predictors
Figure 2 Model 2a: Path analysis model showing associations between 24-month inhibitory control and shyness and later symptoms of
ADHD, ASD and anxiety. Black arrows indicate significant effects at p < .05. Grey arrows are nonsignificant effects. Key pathways of
interest are in bold with standardised beta values attached. Correlations between symptoms of ADHD, anxiety and ASD were included in
the model but are not shown in the diagram for simplicity
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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may be useful in monitoring the emergence of
ADHD-like problems in high-risk infants. In con-
trast, our findings suggest that the early detection of
anxiety is more complex in infants at high-risk for
ASD, and measures used as predictors of anxiety
should be carefully selected to be distinguishable
from early-appearing ASD symptoms.
Limitations and future directions
We used parent-rated measures of early-life predic-
tors and mid-childhood symptoms of ADHD, anxiety
and ASD, which may have been subject to rater ‘halo
effects’ compared to objective measures of early-life
predictors and multi-informant or in-depth clinical
assessments of childhood symptoms. Our sample
size was modest for longitudinal modelling, although
the paths tested in our models were adequately
powered. Post hoc power calculations using chi-
squared difference testing indicate good power to
detect the three main hypothesised pathways (activ-
ity/inhibitory control – hyperactivity and inatten-
tion, and fear/shyness – anxiety), ranging between
71.7% and 99.8% across the four models. The
sample size in the current study precluded a detailed
psychometric approach using multigroup modelling
to assess measurement invariance for the loading of
items onto temperament subscales. This will be
important in future studies to confirm whether the
scales work in a similar way across risk groups. Our
high-risk sample was defined based on risk for ASD
symptoms but not specifically for ADHD and anxiety,
and a proportion of this sample met diagnostic
criteria for ASD. These factors may have influenced
our findings since ADHD and anxiety might manifest
differently in the context of ASD/high-risk for ASD.
Still, our analysis including risk-group, ASD symp-
toms, and ASD outcome as covariates indicated that
our ADHD findings were robust to the influence of
ASD and ASD-risk, although this was not the case
for anxiety. It will be important for future work to
examine developmental pathways to these disorders
in population samples and in multirisk group sam-
ples to assess the generalisability of our findings. We
did not systematically assess the use of interventions
in the high- or low-risk groups and it is possible that
some high-risk children had received interventions
for ASD or other developmental problems, which
may have influenced developmental pathways. Risk
for all three disorders was not evenly distributed
across high- and low-risk children, although we
found no interactions between risk-group and the
early-life predictors that were associated with ADHD
and anxiety respectively. Finally, ASD, ADHD and
anxiety tend to be diagnosed at different ages, with
ASD in early childhood, ADHD in mid-childhood,
and anxiety in later childhood and adolescence
(Beesdo, Knappe, & Pine, 2009; Christensen et al.,
2016; Visser et al., 2014). Given the mid-childhood
age of our sample, it is possible that parent-reports
of anxiety were less reliable than those of ASD and
ADHD, or that anxiety symptoms were not fully
emerged in our sample.
Conclusion
Our findings contribute to understanding the overlap
between ADHD and anxiety symptoms in ASD. Co-
occurring ADHD and ASD might stem from distinct
developmental pathways. In contrast, anxiety and
ASD are difficult to differentiate early in life, perhaps
because they result from shared early developmental
pathways or due to convergence in early behavioural
manifestations of these disorders.
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Key points
• Attention-deficit/hyperactivity disorder (ADHD) and anxiety commonly co-occur in autism spectrum disorder
(ASD), but whether these disorders arise from shared or distinct developmental pathways is unclear.
• Atypical infant and toddler activity levels and inhibitory control predicted mid-childhood ADHD symptoms and
not ASD, suggesting early developmental pathways to ADHD symptoms might be distinct from those that lead
to ASD.
• Atypically high infant and toddler fearfulness and shyness predicted both mid-childhood anxiety and ASD
symptoms, suggesting developmental pathways leading to anxiety may be difficult to distinguish from those
leading to ASD.
• Our findings indicate disorder-specific early detection and intervention targets for ADHD and highlight that
early markers for detecting and treating anxiety may also index ASD.
Note
1. Five DAWBA and five SCQ missing.
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